1. Home
  2. OCUL vs MSEX Comparison

OCUL vs MSEX Comparison

Compare OCUL & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • MSEX
  • Stock Information
  • Founded
  • OCUL 2006
  • MSEX 1897
  • Country
  • OCUL United States
  • MSEX United States
  • Employees
  • OCUL N/A
  • MSEX N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • MSEX Water Supply
  • Sector
  • OCUL Health Care
  • MSEX Utilities
  • Exchange
  • OCUL Nasdaq
  • MSEX Nasdaq
  • Market Cap
  • OCUL 957.3M
  • MSEX 895.1M
  • IPO Year
  • OCUL 2014
  • MSEX N/A
  • Fundamental
  • Price
  • OCUL $7.31
  • MSEX $62.66
  • Analyst Decision
  • OCUL Strong Buy
  • MSEX Hold
  • Analyst Count
  • OCUL 10
  • MSEX 4
  • Target Price
  • OCUL $16.22
  • MSEX $59.33
  • AVG Volume (30 Days)
  • OCUL 1.9M
  • MSEX 247.8K
  • Earning Date
  • OCUL 05-06-2025
  • MSEX 05-07-2025
  • Dividend Yield
  • OCUL N/A
  • MSEX 2.17%
  • EPS Growth
  • OCUL N/A
  • MSEX 39.94
  • EPS
  • OCUL N/A
  • MSEX 2.47
  • Revenue
  • OCUL $63,723,000.00
  • MSEX $191,877,000.00
  • Revenue This Year
  • OCUL $13.32
  • MSEX $10.20
  • Revenue Next Year
  • OCUL $13.13
  • MSEX $6.56
  • P/E Ratio
  • OCUL N/A
  • MSEX $25.39
  • Revenue Growth
  • OCUL 9.03
  • MSEX 15.40
  • 52 Week Low
  • OCUL $4.06
  • MSEX $45.57
  • 52 Week High
  • OCUL $11.78
  • MSEX $70.73
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 51.39
  • MSEX 55.51
  • Support Level
  • OCUL $6.94
  • MSEX $59.37
  • Resistance Level
  • OCUL $7.83
  • MSEX $63.97
  • Average True Range (ATR)
  • OCUL 0.72
  • MSEX 2.29
  • MACD
  • OCUL 0.07
  • MSEX -0.32
  • Stochastic Oscillator
  • OCUL 74.57
  • MSEX 42.62

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm primarily operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

Share on Social Networks: